GET THE APP

Increase of IgE Anti-Encephalitozoon cuniculi Antibody Levels in
Journal of Clinical and Cellular Immunology

Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

+44 1223 790975

Research Article - (2014) Volume 5, Issue 4

Increase of IgE Anti-Encephalitozoon cuniculi Antibody Levels in Septic Patients

Juan C. Andreu-Ballester1*, Constantino Tormo-Calandín2, Carlos Garcia-Ballesteros3, Victoria Amigo3, Ana Peiró-Gómez4, Juan Ruiz Del Castillo5, Carlos Peñarroja-Otero6, Ferran Ballester7, Soledad Fenoy8, Carmen Del Aguila8 and Carmen Cuéllar9
1Head of Research Department, Arnau de Vilanova Hospital, Valencia, Spain
2Professor of Catholic University, School of Medicine, Valencia, Spain
3Hematology Department, Arnau de Vilanova Hospital, Valencia, Spain
4Head of Emergency Department, Arnau de Vilanova Hospital, Valencia, Spain
5Professor in School of Medicine, University of Valencia, Valencia, Spain
6Head of Medicine Department, Casa de la Salud Hospital, Valencia, Spain
7Centre for Public Health Research (CSISP), Valencia, Spain
8Department of Parasitology, San Pablo CEU University, Madrid, Spain
9Department of Parasitology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain
*Corresponding Author: Juan C. Andreu-Ballester, M.D. Ph.D., Research Department, Arnau de Vilanova Hospital, San Clemente 12, 46015, Valencia, Spain, Tel: +34639562863 Email:

Abstract

Objective: We recently demonstrated that the biggest reduction of T cells in septic patients was produced in the γδ T subset. This depletion was directly proportional to the severity of the septic process, and it was associated with mortality. We hypothesized that microsporidia can harness the deficit of γδ T cells in septic patients to proliferate and contribute to the worsening of the sepsis.
Methods: In this retrospective study, we analyzed anti-Encephalitozoon cuniculi antibody levels in sera from 46 septic patients, and compared them with a similar control group of healthy subjects. As a secondary objective we aimed to relate anti-E. cuniculi antibody levels with αβ and γδ T cells in these patients.
Results: Forty-eight percent of septic patients were positive for IgE anti-E. cuniculi vs 13.0% of healthy subjects (OR: 3.67, CI95% 1.64-8.20, P=0.001). The frequency of αβ and CD56+ γδ T cell subsets decreased in septic patients with positive anti-E. cuniculi IgE antibodies. This decrease was more potent in the CD3+CD56+ γδ T cell subset. The genitourinary focus (urinary tract infections and pyelonephritis) produced a significant higher percentage of anti-E. cuniculi positive cases (11/13 (84.6%), OR=11.0, CI 95% 2.1-58.5, P=0.003).
Conclusion: There was a greater level expression of IgE anti-E. cuniculi in septic patients, reaching almost 50% of positive. The presence of IgE anti-E. cuniculi in septic patients was related to a decrease of αβ and γδ T cells in peripheral blood. This decrease was more potent in the CD3+CD56+ γδ T cell subset. Microsporidia may be heavily involved in the physio-pathological evolution of sepsis.

Keywords: Sepsis; Severe sepsis; Septic shock; Microsporidia; Anti-Encephalitozoon cuniculi antibodies; αβ and γδ T cells

Introduction

Sepsis remains a challenge for modern medicine, not only for the steady increase in incidence in all countries but also for its high mortality and health care costs [1-3]. One of the main problems of the septic disease is the etiological diagnosis. In 40-50% of patients the causative organism is undetectable, since cultures are negative [4,5]. This implies that the antibiotic treatment can sometimes be empirical, until culture results. T cells are fundamental in the immune response to infection. T cells are divided into two distinct populations characterized by the TCR receptor expressing on its surface. So, now we can distinguish T cells expressing the αβ-TCR heterodimer (αβ T cells), or the γδ-TCR heterodimer (γδ T cells) [6].

During sepsis, apoptosis has been regarded as an important cause of cell death with a decrease in the number of lymphocytes as well as, epithelial and parenchymal cells [7-9]. We recently demonstrated that a decrease in all lymphocyte subpopulations according to the expression of αβ or γδ TCR receptor is produced in this disease. The higher reduction observed in our study was produced in γδ T cells, and the decrease of this subpopulation was related to mortality of septic patients [10]. This transient diminution of T cells could promote the proliferation of some opportunistic agent and contribute to the severity of the disease.

Microsporidia are obligate intracellular parasites considered as emerging pathogens that have recently been classified as fungi [11,12]. They are ubiquitous and capable of infecting all groups of animals. The organisms are characterized by the production of small and environmental resistant spores which have a unique mode of entering host cells via a polar tube. Three are the species belonging to Encephalitozoon genera isolated from human infections: E. cuniculi, E. hellem and E. intestinalis. They infect both animals and humans, causing opportunistic infections in immunocompromised individuals, such as Acquired Immune Deficiency Syndrome (AIDS), [13-15] although some evidence suggested that asymptomatic infections were common in immunologically stable patients [16,17]. Clinical features of microsporidiosis are broad and include a variety of manifestations such as intestinal, ocular, renal and pulmonary disorders, although the immune status of the host is important in the clinical course of the disease [18]. Clinically silent chronic infections usually developed in immunologically competent hosts, although clinical signs could develop after early infections [19,20]. In these cases, spore shedding has been described occasionally, but detectable amounts of microsporidial DNA may be excreted via urine that could indicate a capacity of microsporidia to disseminate in this population [21,22].

In immunocompromised hosts, microsporidial infections develop into serious diseases that may result in death. The most common clinical symptoms are chronic diarrhea and mal-absorption although, systemic diseases can develop. The first cases were recognized in AIDS patients with CD4+ T lymphocytes lower than 100 cells/ml. However, encephalitozoonosis has also been described in transplant recipients [23,24]. These parasites have been detected in numerous locations producing a great variety of manifestations due to their dissemination capacity. In the case of E. cuniculi infection often produce disseminated disease although diarrhea or interstitial nephritis and cholecystitis have been described.

We propose the hypothesis that microsporidia can harness the deficit of lymphocytes in patients with sepsis to proliferate and contribute to the worsening of the disease.

Our main goal was to quantify the levels of antibodies against E. cuniculi in sera from septic patients compared to a healthy control group. As a secondary objective we aimed to relate anti-E. cuniculi antibody levels with αβ and γδ T cells in these patients.

Material and Methods

Study population

In this retrospective study, sera from 46 patients who met the criteria for sepsis in our previous study were analysed [10]. All patients were admitted to Emergency and Intensive Care Unit of Arnau de Vilanova and Doctor Peset Aleixandre Hospitals of Valencia, Spain. Sepsis was defined according to internationally established criteria [25], as well as their different stages, sepsis without organic failure and with organic failure (severe sepsis) [26,27]. In addition, patients had to meet the following requirements: not suffer immunodeficiency or autoimmune diseases, have not been vaccinated in the last six months, and not be subjected to immunosuppressive therapy. The control group (46 subjects) was recruited from relatives of patients admitted to hospital who were not relatives of septic patients. They should have the same characteristics of the patients in addition to not suffer acute infectious diseases. Both groups were matched by sex and age (± 5 years). The Research and Ethics Committee of both hospitals approved the study.

Blood sample analysis

Blood cell counts were performed using Coulter LH750 automated hematology analyzer (Beckman Coulter, Fullerton, CA). Monoclonal antibodies used: CD45, CD4, CD8, CD3, for the peripheral blood subpopulations and CD4, CD8, CD56, CD2, CD3, TCRαβ and TCRγδ for the T γδ lymphocyte study.

Fluorescence analysis was performed using a Beckman-Coulter multiparameter flow cytometry analyzer, Cytomics FC 500, Florida (USA) and later analyzed with CXP Software. Minimums of 50,000 events were measured. Absolute counts of circulating cell subsets were calculated using the percentages obtained by flow cytometry and the leukocyte count was obtained from the hematological analyzer using a dual-platform counting technology.

γδ T lymphocyte populations were analyzed with Phycoerythrin-Cyanine 5.1 (PC5) conjugated anti-human TCR γδ; Beckman Coulter, Miami, USA (clone: IMMU 510). αβ T lymphocytes were analyzed with Phycoerythrin-Cyanine 5.1 (PC5) conjugated anti-human TCR αβ; Beckman Coulter (Clone: IP26A).

The level of C-reactive protein (CRP) was measured in serum of patients with a heterogeneous enzymatic sandwich immunoassay with an end point immunofluorescence reading method (Vitros Chemistry Products®).

Erythrocyte sedimentation rate (ESR) was measured in the TEST 1 (Alifax, Padovo, Italy) using a quantitative capillary photometry-based technology.

Encephalitozoon cuniculi antigen and determination of specific antibodies

The E. cuniculi antigen was obtained from E. cuniculi (USP-A1) spores cultured on E6 monolayer following Aguila et al. protocol [28]. Briefly, spores were disrupted using glass beads, 2.5% SDS and 2% mercaptoethanol. Soluble antigens were obtained from the supernatant after centrifugation. Protein content was determined by the Bradford method and adjusted to 0.8 μg/ml to coat ELISA plates. Duplicate dilutions of human sera at 1/200 in PBS-Tween, containing 0.1% BSA were added and incubated. Horse radish peroxidase (HRP) conjugate goat anti-human IgG (Biosource International, Camarillo, CA) was used. For IgE determination, test sera were added in duplicate at a 1/2 dilution. A murine monoclonal antibody against e human IgE chain (IgG1κ, E21A11, INGENASA, Madrid, Spain) was added and incubated, followed by a goat anti-mouse IgG1 (gamma) HRP conjugate (CALTAG Laboratories, Burlingame, CA) [29,30]. Values higher than the mean of the Optical Densities (O.D.) of the 46 serum samples of control subjects plus once their standard deviation were considered as E. cuniculi positive.

Statistical analysis

Characteristics of the patients, variables of immunoglobulin levels and lymphocytes subsets in each study group were numerically and graphically described. Normality of distributions was tested by the Kolmogorov-Smirnov test. When normality was accepted, Student t test for paired samples was used to compare the means of quantitative variables. When normality was not accepted, the non-parametric Wilcoxon test was used instead. Differences between cases and controls according to the sepsis categories were always analysed using the Wilcoxon test. Categorical variables were compared by means of Pearson’s Chi-Square test and Spearman’s correlation coefficients. The level of significance was taken as a P value of less than 0.05 (bilateral contrast). Data were analyzed using the statistical software SPSS, version 18.

Results

Characteristics of patients with sepsis

Ninety-two subjects were included in the study, 46 patients with sepsis (29 male and 17 female), and 46 healthy controls with a similar age and sex distribution. The mean age of the patients with sepsis was 61.9 ± 25.4, and the mean age of the controls was 65.6 ± 20.3, P=0.44. Table 1 shows the characteristics of the patients with sepsis.

  Mean ± SD   No. (%) of patients
Age (yrs) 61.9 ± 25.4 Stages of sepsis  
APACHE II score 10.5 ± 4.8 - Sepsis 28 (60.9)
SOFA score 2.0 ± 1.2 - Severe Sepsis 18 (39.1)
ESR 77.6 ± 25.1 Organic Failure  
CRP 313.3 ± 113.1 Acute Renal Failure 7 (15.2)
  No. (%) of patients Neurologic 7 (15.2)
Sex   Acute Respiratory Failure 5 (10.9)
- Male 29 (63.0) Shock 4 (8.7)
- Female 17 (37.0) Acute Hepatic Failure 3 (6.5)
Diagnosis   Hematologic 3 (6.5)
- Pneumonia 13 (28.3) Metabolic 1 (2.2)
- Urinary Tract Infections 12 (26.1) No. Organs with failure  
- Acute Appendicitis 6 (13.0) 0 28 (60.9)
- Acute Cholecystitis 5 (10.9) 1 12 (26.1)
- Acute Cholangitis 3 (6.5) 2 3 (6.5)
- Enterocolitis 2 (4.3) 3 1 (2.2)
- Acute Diverticulitis 1 (2.2) 4 1 (2.2)
- Abscess 1 (2.2) 5 1 (2.2)
- Pelvic inflammatory disease 1 (2.2) Positive Cultures 19 (41.3)
- Undetermined 2 (4.3) In-hospital death 4 (8.7)

Table 1: Characteristics of Patients with Sepsis (N=46).

Continuous variables are expressed as means ± Standard Deviation (SD). C-reactive protein (CRP). Erythrocyte sedimentation rate (ESR). Positive cultures included blood (n=12), urine (n=6), sputum (n=2), exudate (n=1), stool (n=1). Severe Sepsis included Septic Shock (N=4). Undetermined sepsis represents the patient with fever and well-defined criteria of systemic inflammatory response without a well-defined septic focus. In our study, 2 patients with undetermined sepsis had positive blood cultures for Escherichia coli.

Anti-Encephalitozoon cuniculi antibodies

IgE anti-E. cuniculi levels of septic patients were almost double those of healthy control subjects (Figure 1A). However, no differences were observed when patients with sepsis and severe sepsis were compared (Figure 1B). Moreover, not significant differences were observed between the control group and the two groups of sepsis related to serum levels of IgG anti-E. cuniculi.

clinical-cellular-immunology-Anti-Encephalitozoon

Figure 1: Anti-Encephalitozoon cuniculi antibody levels measured by ELISA (IgG and IgE). (A) Sepsis (N=46) vs Control group (N=46). (B) Uncomplicated sepsis (N=28), Severe sepsis (N=18). Immunoglobulins are expressed in means of Optical Density (O.D.) values and T-bars denote standard deviation. *P<0.001.

IgG and IgE anti-E. cuniculi levels were analyzed according to the time of evolution of sepsis. The highest levels of specific IgG were obtained after three days from the onset of symptoms (fever) compared to the group of patients with a lower time of evolution (1-2 days) (P=0.034). No differences were seen in the case of anti-E. cuniculi IgE levels.

T cell subsets in septic and control healthy subjects

The frequency of αβ (Figure 2A) and γδ (Figure 2B) T cell subsets was greatly diminished in septic patients vs control healthy subjects. The frequency of αβ T cells in patients with severe sepsis was decreased more significantly than in patients with non-severe sepsis and this decrease was only significant in CD3+ and CD3+CD4+ αβ T cells. However, all γδ T cell subsets significantly decreased in severe sepsis vs organic uncomplicated sepsis.

clinical-cellular-immunology-cells-subsets

Figure 2: Frequencies of T cells subsets according to type of receptor αβ (A) and γδ (B), in septic patients and control group. Values are expressed as means (×109/L) and T-bars denote standard deviation. Differences between control group and patients with sepsis (P <0.001).

IgE-IgG anti-Encephalitozoon cuniculi antibodies and αβ-γδ T cell subsets

Twenty-two of the 46 patients with sepsis (47.8%) were IgE anti-E. cuniculi positive vs 6/46 (13.0%) in the control healthy group (OR: 3.67, CI 95% 1.64-8.20, P=0.001). When the mean frequency of αβ-γδ T cell subsets was analyzed in the septic group of patients according to IgE anti-E. cuniculi positive-negative diagnostic, we observed a significant reduction in the case of all αβ T cell subsets in the group of patients with IgE anti-E. cuniculi positive levels (Figure 3A), as well as, in the case of CD3+ and CD3+CD56+ γδ T cells (Figure 3B). However, only 8/46 (17.4%) septic patients were IgG anti-E. cuniculi positive vs 11/46 (23.9%) observed in the control healthy group (OR: 0.83, CI 95% 0.53-1.30, P=0.61). Although the αβ T cell population was always reduced in the group of septic patients that were IgG anti-E. cuniculi positive, we only observed significant differences in the case of CD3+CD56+ αβ T cells.

clinical-cellular-immunology-Optical-Densities

Figure 3: Frequencies of αβ (A) and γδ (B) T cells in septic patients according to positive and negative IgE anti-Encephalitozoon cuniculi antibody levels. Frequencies are expressed as means (× 109/L) and T-bars denote standard deviation. N: Negative; P: Positive. Values higher than the mean of the Optical Densities (O.D.) of the serum samples plus once their standard deviation were considered as IgE positive.

Correlations among anti-Encephalitozoon cuniculi IgG and IgE levels with T cell subsets

In the healthy group, anti-E. cuniculi antibodies were negatively correlated with CD3+CD56+ αβ T cell values, in both IgE (Spearman rho: -0.594, P=0.001) and IgG isotypes (Spearman rho: -0.468, P=0.001). Likewise, CD3+CD56+ γδ T cells were negatively correlated with IgE anti-E. cuniculi (Spearman rho: -0.447, P=0.002). This means that the greater the number of CD3+CD56+ T cells the smaller the amount of anti-E. cuniculi antibodies (Figure 4A-4C).

clinical-cellular-immunology-healthy-group

Figure 4: Correlations between IgG and IgE anti-Encephalitozoon cuniculi levels and T cells in healthy group. (A) Spearman rho (-0.594, P =0.001); (B) Spearman rho (-0.468, P =0.001); (C) Spearman rho (-0.447, P =0.002). Immunoglobulines are expressed as means of Optical Density (O.D.). T cell values are expressed as means (×109/L). Correlations between IgG anti-E. cuniculi levels and T cells in severe sepsis. (D) Spearman rho (+0.607, P =0.010); E: Spearman rho (+0.567, P =0.018); F: Spearman rho (+0.627, P =0.007). Immunoglobulines are expressed as means of Optical Density (O.D.). T cell values are expressed as means (×109/L).

However, in the group of patients with severe sepsis we observed a positive correlation between IgG anti-E. cuniculi antibodies and CD3+ γδ T cells (Spearman rho: +0.607, P=0.010), CD3+CD4-CD8- γδ T cells (Spearman rho: +0.607, P=0.010) and CD3+CD56+ γδ T cells (Spearman rho: +0.627, P=0.007). This means that the greater the number of CD3+ γδ T cells the greater the amount of IgG anti-E. cuniculi antibodies (Figure 4D-4F).

Septic focus and IgG and IgE anti-Encephalitozoon cuniculi antibodies

When the association of septic focus with the percentage of patients with detectable levels of IgE anti-E. cuniculi was studied, the genitourinary focus (urinary tract infections and pyelonephritis) produced a significant higher percentage of positive cases (11/13 (84.6%), OR=11.0, CI 95% 2.1-58.5, P=0.003). On the other hand, abdominal and respiratory foci showed 29.4% and 23.1% of positive results, respectively.

The analysis of the organisms according to Gram stains with respect to IgE anti-E. cuniculi specific antibodies showed no relation between Gram positive organisms and presence of specific IgE. Instead, 69.2% (9/13) of the patients who were positive for Gram negative organism were IgE anti-E. cuniculi positive (OR=3.5, CI 95% 0.9-13.6, P=0.067). Table 2 shows the organisms isolated from cultures of different sample types from septic patients.

  N (%) Blood Urine Sputum Exudate Feces
Gram-negative
-Escherichia coli 11 6 5      
-Pseudomona 1 1        
-Proteus mirabilis 1   1      
-Bacteroides fragilis 1       1  
-Klebsiella pneumoniae 1 1        
-Salmonella 1         1
-Haemofilus influenzae 1     1    
-Proteus vulgaris 1   1      
Total Cultures N (%) 18 (78.3) 8 (34.8) 7 (30.4) 1 (4.3) 1 (4.3) 1 (4.3)
Gram-positive
-Streptococcus pneumoniae 2 2        
-Enterococcus faecalis 1 1        
-Staphylococcus epidermidis 1 1        
Total Cultures N (%) 4 (17.4) 4 (17.4)        
Fungus
-Candida albicans 1 (4.3)     1    
Total Cultures N (%) 23 (100.0) 12 (52.2) 7 (30.4) 2 (8.6) 1 (4.3) 1 (4.3)

Table 2: Organisms isolated from cultures of different sample types from septic patients.

Discussion

This is the first study that evaluates IgE and IgG anti-E. cuniculi antibody levels in septic patients, demonstrating that these patients had anti-E. cuniculi specific IgE levels higher than healthy subjects.

In an experimental study in mice, Furuya et al. [31] obtained three monoclonal antibodies against tube polar protein 1 (PTP1) of E. cuniculi belonging to the IgE isotype. These antibodies also recognized intracellular antigens. The high levels of IgE anti-E. cuniculi antibodies produced by septic patients may be indicative of the presence of microsporidia in the host’s organs causing a primary immune response. This fact could be also indicating an increase in proliferation of these opportunistic agents provoking an acute infection.

Interestingly, IgG anti-E. cuniculi levels in septic patients were similar to those observed in sera from healthy subjects. This could indicate that the parasite did not induce an adequate and permanent adaptive immune response in these patients. This could be caused by an immune deficiency in these patients that did not provide proper immune responses. In this regard, we recently reported that a deficit of γδ T cells [32] and interleukin-7 [33] in Crohn’s disease patients, was related to a higher production of IgE anti-E. cuniculi antibodies. Likewise, 30% of Crohn’s disease patients were positive by real time PCR for microsporidia while all subjects of the control group were negative, suggesting that Crohn’s disease patients are a group at risk of microsporidiosis. Moreover microsporidia may be involved as a possible etiologic factor of Crohn’s disease [34].

As expected, αβ and γδ T cell levels in septic patients were lower than the observed in the control group. CD3+ and CD3+ CD4+ αβ T cells significantly diminished in patients with severe sepsis with respect to the organic uncomplicated sepsis. All the γδ T cell subsets were significant lower in the severe sepsis patient group. It is interesting to note that almost 50% of septic patients showed IgE anti-E. cuniculi positive levels and decreases in all αβ T cell subsets were significant in IgE positive patients. However, in the γδ T cell population significant decreases were only observed for CD3+ and CD3+ CD56+ phenotypes. This fact is important to bear in mind, taking into account that the mortality in patients with sepsis was associated with a reduction in γδ T cells, specifically the CD3+ CD56+ γδ T subset [10].

Natural killer T cells (NKT cells) belong to the innate immune response because they act in minutes or hours after antigen contact. NKT cells are an ongoing source of confusion in the literature. Flow cytometry revealed that up to 55% of hepatic, but <6% of peripheral CD3+ lymphocytes expressed CD56, CD161; besides, they expressed αβ or γδ TCR [35].

Godfrey et al. [36,37] defined three types of NKT cells: Type I cells (classical NKT-cells), type II cells (non-classical NKT-cells) both CD1 d-restricted and NKT-like cells (CD1d-independent NK1.1*T cells). Several subsets of γδ T cells also express NK-cell markers such as NK1.1 [38], and these are usually not CD1d specific, so they have been included under the category of NKT-like cells. CD3+CD56+ αβ and γδ T cells analyzed in our patients can be included into the NKT-like cell category. Experimental studies in mice have shown the role of NKT cells in the pathophysiology of sepsis. However, the role of NKT cells expressing the γδ receptor on sepsis is unknown [39]. Moreover, how NKT cells respond to fungi is unknown. In our study, the average levels of αβ and γδ NKT cells were below 50% in subjects with positive anti-E. cuniculi IgE (Figure 3). This decrease was more intense than the observed with the other T cell subsets.

Both CD3+CD56+ αβ and γδ T cell subsets were closely related to anti-E. cuniculi immune responses in healthy subjects. We have not found previous studies that report this subset in immunity against this pathogen in humans. There is only a study that showed an enhanced NK activity in a murine experimental infection by E. cuniculi [40]. Thus, in healthy control subjects there was an inverse relationship between anti-E. cuniculi antibody levels and CD3+CD56+ cells. This suggested that this T cell phenotype could have a direct effect on these microsporidia and their diminution can cause a lower stimulation of the specific antibody production. By contrast, in patients with severe sepsis, the correlation between CD3+CD56+ cells and specific IgG was positive, but no correlation with specific IgE was observed although specific IgE antibodies are involved in the experimental responses against this opportunistic agent [31]. Works are in progress in order to clear different immunological responses in health and septic subjects against microsporidia.

According to our results, microsporidia could be involved in the evolution of sepsis. They could be the root cause of the infections that trigger misdiagnosed sepsis. Nowadays, it is known that microsporidia can only be propagated in cell culture systems [41]. However, the use of cell cultures in routine clinical diagnosis is time consuming and laborious and only specialized laboratories maintain cell cultures with microsporidia. The best alternative is the use of serological tests with whole organisms or recombinant polar tube protein or spore wall protein as antigens [42].

It is known that γδ T cells can be selectively activated by natural or synthetic phosphoantigens [43] and act by means of antibody-dependent cell-mediated cytotoxicity in the absence of an allogenic response [44]. For this reason, they could be potential candidates for therapy in patients with sepsis. In addition, some antibiotics have shown partial efficacy in the therapy of microsporidia [45].

Increasing evidence supports a central role for immunosuppression in sepsis. The initial immune response in sepsis is hyperinflammatory (cytokine storm), but the response rapidly progresses to a hypoinflammatory response (immunosuppression) [46]. This immune dysfunction may be lead to increase the host susceptibility to secondary opportunistic infections [47]. Our findings demonstrated that microsporidia may be heavily involved in the evolution of sepsis and justify the need for new investigations on antimicrobial agents against these opportunistic agents.

Acknowledgment

Our thanks go to AnselmoVillar-Grimalt, M.D., Ph.D., Head of Internal Medicine Department, and José Mayans, M.D., Ph.D., Head of Hematology Department, for their unconditional support for our work. We thank the nursing and medical staff of the Arnau de Vilanova Hospital, and Dr. Peset Aleixandre Hospital for their help in collecting and preparing blood samples.

References

  1. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
  2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
  3. Andreu Ballester JC, Ballester F, González Sánchez A, Almela Quilis A, Colomer Rubio E, et al. (2008) Epidemiology of sepsis in the Valencian Community (Spain), 1995-2004. Infect Control Hosp Epidemiol 29: 630-634.
  4. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34: 344-353.
  5. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, et al. (2001) Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709.
  6. Saito H, Kranz DM, Takagaki Y, Hayday AC, Eisen HN, et al. (1984) Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature 309: 757-762.
  7. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, et al. (1997) Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 25: 1298-1307.
  8. Hotchkiss RS, Dunne WM, Swanson PE, Davis CG, Tinsley KW, et al. (2001) Role of apoptosis in Pseudomonas aeruginosa pneumonia. Science 294: 1783.
  9. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166: 6952-6963.
  10. Andreu-Ballester JC, Tormo-Calandín C, Garcia-Ballesteros C, Pérez-Griera J, Amigó V, et al. (2013) Association of γδ T cells with disease severity and mortality in septic patients. Clin Vaccine Immunol 20: 738-746.
  11. Keeling PJ, Fast NM (2002) Microsporidia: biology and evolution of highly reduced intracellular parasites. Annu Rev Microbiol 56: 93-116.
  12. Lee SC, Corradi N, Doan S, Dietrich FS, Keeling PJ, et al. (2010) Evolution of the sex-related locus and genomic features shared in microsporidia and fungi. PLoS One 5: e10539.
  13. Eeftinck Schattenkerk JK, van Gool T, van Ketel RJ, Bartelsman JF, Kuiken CL, et al. (1991) Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 337: 895-898.
  14. Blanshard C, Gazzard BG (1991) Microsporidiosis in HIV-1-infected individuals. Lancet 337: 1488-1489.
  15. Weber R, Deplazes P, Flepp M, Mathis A, Baumann R, et al. (1997) Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N Engl J Med 336: 474-478.
  16. van Gool T, Vetter JC, Weinmayr B, Van Dam A, Derouin F, et al. (1997) High seroprevalence of Encephalitozoon species in immunocompetent subjects. J Infect Dis 175: 1020-1024.
  17. Enriquez FJ, Taren D, Cruz-López A, Muramoto M, Palting JD, et al. (1998) Prevalence of intestinal encephalitozoonosis in Mexico. Clin Infect Dis 26: 1227-1229.
  18. Didier ES (2005) Microsporidiosis: an emerging and opportunistic infection in humans and animals. Acta Trop 94: 61-76.
  19. Snowden KF, Didier ES, Orenstein JM, Shadduck JA (1998) Animal models of human microsporidial infections. Lab Anim Sci 48: 589-592.
  20. Sak B, Brady D, Pelikánová M, Kvetonová D, Rost M, et al. (2011) Unapparent microsporidial infection among immunocompetent humans in the Czech Republic. J Clin Microbiol 49: 1064-1070.
  21. García LS (2007) Intestinal Protozoa (Coccidia and Microsporidia) and Algae. In: Garcia LS, Bruckner DA (Eds) Diagnostic Medical Parasitology. ASM Press, Washington D.C. pp: 57-101.
  22. Sak B, Kvác M, Kucerová Z, Kvetonová D, Saková K. (2011) Latent microsporidial infection in immunocompetent individuals - a longitudinal study. PLoS Negl Trop Dis 5: e1162.
  23. Talabani H, Sarfati C, Pillebout E, van Gool T, Derouin F, et al. (2010) Disseminated infection with a new genovar of Encephalitozoon cuniculi in a renal transplant recipient. J Clin Microbiol 48: 2651-2653.
  24. George B, Coates T, McDonald S, Russ G, Cherian S, et al. (2012) Disseminated microsporidiosis with Encephalitozoon species in a renal transplant recipient. Nephrology (Carlton) 17 Suppl 1: 5-8.
  25. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256.
  26. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 30: 536-555.
  27. Poeze M, Ramsay G, Gerlach H, Rubulotta F, Levy M (2004) An international sepsis survey: a study of doctors' knowledge and perception about sepsis. Crit Care 8: R409-413.
  28. del Aguila C, Rueda C, De la Camara C, Fenoy S (2001) Seroprevalence of anti-Encephalitozoon antibodies in Spanish immunocompetent subjects. J Eukaryot Microbiol Suppl: 75S-78S.
  29. Daschner A, Cuéllar C, Sánchez-Pastor S, Pascual CY, Martín-Esteban M (2002) Gastro-allergic anisakiasis as a consequence of simultaneous primary and secondary immune response. Parasite Immunol 24: 131-136.
  30. Gutiérrez R, Cuéllar C (2002) Immunoglobulins anti-Anisakis simplex in patients with gastrointestinal diseases. J Helminthol 76: 131-136.
  31. Furuya K, Miwa S, Omura M, Asakura T, Yamano K, et al. (2008) Mouse monoclonal immunoglobulin E antibodies specific for the microsporidian Encephalitozoon cuniculi polar tube protein 1. Hybridoma (Larchmt) 27: 153-157.
  32. Andreu-Ballester JC, Amigó-García V, Catalán-Serra I, Gil-Borrás R, Ballester F, et al. (2011) Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn's disease. Dig Dis Sci 56: 2613-2622.
  33. Andreu-Ballester JC, Pérez-Griera J, Garcia-Ballesteros C, Amigo V, Catalán-Serra I, et al. (2013) Deficit of interleukin-7 in serum of patients with Crohn's disease. Inflamm Bowel Dis 19: E30-31.
  34. Andreu-Ballester JC, Garcia-Ballesteros C, Amigo V, Ballester F, Gil-Borrás R, et al. (2013) Microsporidia and its relation to Crohn's disease. A retrospective study. PLoS One 8: e62107.
  35. Norris S, Doherty DG, Collins C, McEntee G, Traynor O, et al. (1999) Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum Immunol 60: 20-31.
  36. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what's in a name? Nat Rev Immunol 4: 231-237.
  37. Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nat Immunol 11: 197-206.
  38. Lees RK, Ferrero I, MacDonald HR (2001) Tissue-specific segregation of TCRgamma delta+ NKT cells according to phenotype TCR repertoire and activation status: parallels with TCR alphabeta+NKT cells. Eur J Immunol 31: 2901-2909.
  39. Niederkorn JY, Brieland JK, Mayhew E (1983) Enhanced natural killer cell activity in experimental murine encephalitozoonosis. Infect Immun 41: 302-307.
  40. Visvesvara GS (2002) In vitro cultivation of microsporidia of clinical importance. Clin Microbiol Rev 15: 401-413.
  41. Didier ES, Weiss LM (2006) Microsporidiosis: current status. Curr Opin Infect Dis 19: 485-492.
  42. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, et al. (1994) Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264: 267-270.
  43. Lamb LS Jr, Musk P, Ye Z, van Rhee F, Geier SS, et al. (2001) Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response. Bone Marrow Transplant 27: 601-606.
  44. Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ (2005) Therapeutic strategies for human microsporidia infections. Expert Rev Anti Infect Ther 3: 419-434.
  45. Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13: 862-874.
  46. Monneret G, Venet F, Kullberg BJ, Netea MG (2011) ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 49 Suppl 1: S17-23.
Citation: Andreu-Ballestera JC, Tormo-Calandín C, Garcia-Ballesteros C, Amigo V, Peiró-Gómez A, et al. (2014) Increase of IgE Anti-Encephalitozoon cuniculi Antibody Levels in Septic Patients. J Clin Cell Immunol 5:244.

Copyright: © 2014 Andreu-Ballestera JC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top